Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2025-12-24 @ 9:22 PM
NCT ID:
NCT02507804
Eligibility Criteria:
Inclusion Criteria:
* Adult patients aged 18 or over; no upper age limit.
* Cancer requiring commencement of chemotherapy (any line) with a regime containing at least 6 cycles (of any cycle duration).
* Chemotherapy may include any systematic anti-cancer therapy (i.e. cytotoxic agents, immunotherapy or targeted therapy) provided this is delivered as induction therapy.
* Expectation to complete cycles 1 through 6 of planned therapy.
* The capacity to understand the Patient Information Sheet and provide written informed consent.
* Non English speaking patients may enter the study if an English speaking friend or relative is willing to assist the patient.
* Willingness and ability to comply with study procedures.
* A patient enrolled on a concurrent IMP clinical trial is permitted at the Investigators discretion.
Exclusion Criteria:
* Patients who have already commenced therapy for their current disease episode i.e. received at least their first cycle of chemotherapy.
* Patients receiving chemotherapy/ radio-immunotherapy as the sole modality of treatment.
* Patients who have completed induction therapy and due to commence maintenance therapy.
* Uncontrolled medical condition that in the opinion of the Investigator may jeopardise completion of 6 cycles of treatment.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02507804
Study Brief:
Protocol Section:
NCT02507804